Increased activation of Th17 together with a decreased activity of CD4+ regulatory T lymphocytes (Treg) has been observed in severe COVID-19 patients, while the imbalanced ratio Th17/Treg is strongly associated with hyperinflammation, lung damage and disease pathogenesis. The gene discussed is CD4; the disease is COVID-19.